Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Epilepsy × Memantine × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 8 Glioblastoma 3 Neoplasm Metastasis 2 Small Cell Lung Carcinoma 1 Recurrence 1 Neurotoxicity Syndromes 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lung Neoplasms 1 Gliosarcoma 1 Gastrointestinal Neoplasms 1 Epilepsy 1 Ependymoma 1 Craniopharyngioma 1 Cognitive Dysfunction 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

ziprasidone 1 perampanel 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topotecan 1 Tobramycin 1 Temozolomide 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Radiotherapy 1 Propofol 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nitrous Oxide 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Memantine 1 Magnetoencephalography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡